Table I.
Studies reporting interventional SMA treatment
| Author, year, patients | Vessels | Age (y), sex (%) |
Technical (techn.), clinical (clin.) success, morbidity, mortality | Patency rate | Pure PTA / stent |
|---|---|---|---|---|---|
| Pietura, 2002, (n = 6) [17] |
TC 4, SMA 5 | 46–73 y, 5 m (83%) |
100% morbidity/mortality: 0 |
no restenosis after 12–18 months | only one stenting after unsuccessful PTA |
| AbuRahma, 2003, (n = 22) [18] |
TC 12, SMA 8, both 2 |
69.2 (52–88) y, 3 m (14%) |
96%/95% mortality: 0 |
30% after mean 26 months | all PTA/stent |
| Sharafuddin, 2003, (n = 25) [19] |
TC 11, SMA 18 | 66 (41–86) y, 13 m (52%) |
96%/88% morbidity: 10%, 30 d mortality: 4% |
6 months: 92% | all PTA/stent |
| Chahid, 2004, (n = 14) [10] |
TC 3, SMA 8, both 3 |
53 (32–74) y, 6 m (43%) |
100%/100% morbidity: 14%, mortality: 0 |
14% after mean 29 months | 9 : 5 |
| Lee, 2008, (n = 31) [13] |
TC 15, SMA 26 | 70 (43–90) y, 5 m (16%) |
techn.: 97.5% morbidity: 6%, 30 d mortality: 14% |
1 year: 85% no restenosis | |
| Sarac, 2008, (n = 65) [15] |
TC 23, SMA 57, IMA 7 | 70 (44–89) y, 29 m (45%) |
clin.: 85% morbidity: 31%, 30 d mortality: 8% |
1 year: 65% | all PTA/stent |
| Zerbib, 2008, (n = 14) [20] |
TC 2, SMA 12 | 75.4 ± 10.1 y, 8 m (57.2%) |
92.8% morbidity: 21%, 3 mon. mortality: 14.2% |
primary restenosis 21.4% after PTA, pain relief at the end of the study 71.4% | 3 : 11 s |
| Daliri, 2010, (n = 17) [21] |
TC 13, SMA 13 | 65 (31–89) y, 4 m (24%) |
100%/88%mortality: 18% | 1 year: 81%, reintervention rate 30% |
13 : 13 |
| Fioole, 2010, (n = 51) [22] |
TC 30, SMA 24, IMA 6 | 64 ± 11 y, 26 m (51%) |
93%/78% morbidity: 4%, 30 d mortality: 0 |
1 year: 86% 2 years: 60% |
All PTA/stent |
| Jung, 2011, (n = 18) [23] |
TC 6, SMA 16, IMA 1 | 61.5 (43–84) y, 13 m (72%) | 3× recurrence after 6/8/8 months | 94% PTA/stent | |
| Turba, 2012, (n = 166) [24] |
TC 66, SMA 120, IMA 35 | 69 (40–94) y, 54 m (33%) |
97%/88.2% morbidity: 3.6%, 30 d mortality: 3% |
1 year: CT, SMA, IMA 85%, 88%, 84% | 50 : 165 |